Related Articles
Skin rash in the intensive care unit: Stevens‑johnson syndrome, toxic epidermal necrolysis, or a rare manifestation of a hidden cutaneous malignancy: A case report
Purulent bullous epidermal necrolysis: A potential new clinical pattern of drug eruption
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review)
Stevens‑Johnsons syndrome or drug‑induced lupus ‑ a clinical dilemma: A case report and review of the literature
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient